TELA Bio, Inc.
TELA Bio, Inc., a pioneering medical technology company headquartered in the United States, specialises in the development of innovative surgical solutions. Founded in 2012, TELA Bio has made significant strides in the field of regenerative medicine, focusing on advanced biomaterials for soft tissue reconstruction. The company’s flagship products, including the OviTex® line of biologic mesh, are designed to enhance healing and reduce complications in surgical procedures. TELA Bio's unique approach combines the benefits of biologic and synthetic materials, setting it apart in a competitive market. With a strong presence across major operational regions in the US, TELA Bio has established itself as a leader in the surgical implant industry, recognised for its commitment to improving patient outcomes and advancing surgical techniques.
DitchCarbon Score
How does TELA Bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TELA Bio, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TELA Bio, Inc.'s reported carbon emissions
TELA Bio, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As TELA Bio does not inherit emissions data from a parent company or corporate family, all information regarding climate commitments remains unspecified. Without concrete emissions data or reduction initiatives, it is unclear how TELA Bio is addressing its carbon footprint or contributing to climate action within the medical technology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TELA Bio, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
